Primary Human Papillomavirus Screening: Women’s Perceptions of New Cervical Cancer Screening Recommendations
Journal of Women's Health · 2024
DOI: 10.1089/jwh.2023.1180 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Women's Health, 2024. Verfasst von Nancy T Cannizzaro und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Research and Evaluation, Kaiser Permanente, Pasadena, California, USA. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, Early Detection of Cancer, Papillomavirus Infections, Health Knowledge, Attitudes, Practice. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 46 Literaturangaben.
Abstract (Originalsprache)
Background
Current clinical guidelines recommended primary human papillomavirus (HPV) screening for cervical cancer testing. Previous studies reported patient-level barriers (e.g., limited knowledge and attachment to Pap test) that may hinder wide adoption of primary HPV screening. We assessed these women-level factors following the implementation of primary HPV screening (July 2020) at Kaiser Permanente Southern California (KPSC).
Methods
We administered a patient survey (mail and on-line) to female KPSC members aged 30-65 years who received primary HPV screening between October and December 2020. Those who preferred English vs. Spanish language were sampled separately. The survey included domains on knowledge about HPV and HPV screening, awareness of screening guidelines, and attitudes about HPV testing. Demographic data were collected using electronic health records. We used weighted multivariable logistic and modified Poisson regressions for associations between language preference and survey responses.
Results
In total, 3,009 surveys were returned (38.0% response rate). Few women (7.0%) found HPV testing as an acceptable screening method. The majority of women (92.2%) remained unaware that HPV testing can replace Pap test for screening. The Pap test was the most preferred screening approach for 33.2% Spanish-speaking women vs. 19.9% English-speaking women. Only 20.6% knew that women aged 30-65 years can be screened every 5 years with cotest or primary HPV screening. Most women (96.4%) did not perceive stigma about taking the HPV test.
Conclusion
Proactive patient education will help improve women's knowledge about primary HPV screening, which may facilitate its implementation in additional health care settings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Research and Evaluation, Kaiser Permanente, Pasadena, California, USA.
- Department of Health Systems Science, Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, California, USA.
- Department of Obstetrics and Gynecology, Kaiser Permanente, Irvine, California, USA.
Zitieren
APA
Cannizzaro, N. T., Mittman, B. S., Hahn, E. E., Ngo-Metzger, Q., Gould, M. K., Hsu, C., Shen, E., Tewari, D., & Chao, C. R. (2024). Primary Human Papillomavirus Screening: Women’s Perceptions of New Cervical Cancer Screening Recommendations. Journal of Women's Health. https://doi.org/10.1089/jwh.2023.1180
Vancouver
Cannizzaro NT, Mittman BS, Hahn EE, Ngo-Metzger Q, Gould MK, Hsu C, et al. Primary Human Papillomavirus Screening: Women’s Perceptions of New Cervical Cancer Screening Recommendations. Journal of Women's Health. 2024. doi:10.1089/jwh.2023.1180
BibTeX
@article{Cannizzaro2024,
author = {Cannizzaro, Nancy T and Mittman, Brian S and Hahn, Erin E and Ngo-Metzger, Quyen and Gould, Michael K and Hsu, Chunyi and Shen, Ernest and Tewari, Devansu and Chao, Chun R},
title = {Primary Human Papillomavirus Screening: Women’s Perceptions of New Cervical Cancer Screening Recommendations},
journal = {Journal of Women's Health},
year = {2024},
doi = {10.1089/jwh.2023.1180}
}
EUVIMED